Papers
2
Total Citations
18
H-Index
2
About
Luca Mazzola is a urologic surgeon and researcher whose work centers on the surgical management of renal cell carcinoma, with a particular focus on robot-assisted partial nephrectomy (RAPN). His major contributions lie in refining surgical techniques and prognostic classification for kidney cancer patients. Notably, his 2022 study on upstaged pT3a renal tumors with fat invasion proposed a new subclassification to better predict outcomes, a work that has already garnered 10 citations and sparked discussion in the field. In his 2025 narrative review, Mazzola systematically examined RAPN across diverse clinical scenarios, reinforcing its status as the gold standard for cT1 renal masses by highlighting superior functional outcomes and reduced perioperative morbidity compared to open or laparoscopic approaches. With a growing citation impact, Mazzola is shaping how surgeons approach complex kidney tumors, blending technical innovation with evidence-based risk stratification. His research not only advances surgical practice but also offers practical guidance for clinicians navigating challenging cases, making him a rising voice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2